Q32 Bio Inc.
QTTB
$1.94
$0.052.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 5.66% | -97.49% | |||
| Gross Profit | -5.66% | 97.49% | |||
| SG&A Expenses | -21.43% | 28.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.87% | -22.18% | |||
| Operating Income | 18.87% | 22.18% | |||
| Income Before Tax | 13.98% | 30.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.98% | 22.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.98% | 22.26% | |||
| EBIT | 18.87% | 22.18% | |||
| EBITDA | 18.82% | 22.36% | |||
| EPS Basic | 13.99% | 22.36% | |||
| Normalized Basic EPS | 5.19% | 68.48% | |||
| EPS Diluted | 13.75% | 22.36% | |||
| Normalized Diluted EPS | 5.19% | 68.48% | |||
| Average Basic Shares Outstanding | 0.00% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||